BIOGEN INC. (BIIB) Total liabilities 2016–2025
BIOGEN INC. (BIIB) total liabilities at each fiscal year-end, per SEC filings.
$11.2BFY2025 · since FY2016: $10.7B → $11.2B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $11.2B | -1.3% |
| FY2024 | $11.3B | -5.9% |
| FY2023 | $12.0B | +7.9% |
| FY2022 | $11.2B | -13.6% |
| FY2021 | $12.9B | -7.3% |
| FY2020 | $13.9B | +0.3% |
| FY2019 | $13.9B | +13.4% |
| FY2018 | $12.3B | +10.9% |
| FY2017 | $11.1B | +2.8% |
| FY2016 | $10.7B | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More BIIB financial trends
BIIB RevenueBIIB Net incomeBIIB Net marginBIIB Gross profitBIIB Gross marginBIIB Operating incomeBIIB Operating marginBIIB Operating cash flowBIIB Free cash flowBIIB Capital expendituresBIIB Return on equityBIIB Stock buybacksBIIB Dividends paidBIIB Total assetsBIIB Shareholders’ equityBIIB overview →